A study in Health Economics uncovers a major unintended consequence of abortion‐related regulations: a measurable decline in the availability of obstetricians and gynecologists.
Since 2010, increasing numbers of states across the US have enacted Targeted Regulation of Abortion Providers (TRAP) laws that require abortion clinics to adhere to stringent and often medically unnecessary standards. By analyzing 2010–2021 data, investigators found that TRAP laws significantly reduced the supply of obstetricians and gynecologists—particularly older and newly trained doctors—without corresponding increases in midwives, nurse practitioners, and physician assistants who practice women’s health care. TRAP law enactment was associated with a reduction in more than 2 obstetrician‐gynecologists per 100,000 females aged 15–44 years.
“These findings reveal that abortion restrictions can have much broader effects on maternal healthcare access, raising important considerations for policymakers and healthcare systems nationwide,” said corresponding author Quan Qi, PhD, a postdoctoral fellow at Johns Hopkins University, who conducted the research as part of her doctoral dissertation at the University at Albany, State University of New York.
URL: https://onlinelibrary.wiley.com/doi/10.1002/hec.70087
Additional Information
NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. For more information or to obtain a PDF of any study, please contact: Sara Henning-Stout, newsroom@wiley.com.
About the Journal
Health Economics is an international health policy journal publishing articles on all aspects of global health economics. We welcome theoretical contributions, empirical studies, and analyses of health policy from the economic perspective. With a wide scope, Health Economics welcomes contributions on the valuation, determinants and definition of health, health care supply and demand, planning and market mechanisms, treatment micro-economics, and health care system performance.
About Wiley
Wiley is a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning. With more than 200 years at the center of the scholarly ecosystem, Wiley combines trusted publishing heritage with AI-powered platforms to transform how knowledge is discovered, accessed, and applied. From individual researchers and students to Fortune 500 R&D teams, Wiley enables the transformation of scientific breakthroughs into real-world impact. From knowledge to impact—Wiley is redefining what's possible in science and learning. Visit us at Wiley.com and Investors.Wiley.com. Follow us on Facebook, X, LinkedIn and Instagram.